LATS1 and hepatocellular carcinoma: Finally, increasing miR-106b-5p levels could significantly reduce the mRNA and protein levels of LATS1 in HCC cells, whereas miR-106b-5p inhibitor could markedly increase these levels (Figure 5(g,h)).